Orthox was founded in 2008 by Dr Nick Skaer and Prof Oliver Kessler to commercialise silk technology developed by Prof Fritz Vollrath’s Silk Group at the University of Oxford.

The Company is developing tissue regenerative knee implants to help patients with cartilage damage return to a fully active, pain free life. Orthox’s FibroFix™ technology is based on a protein produced by the silk moth, Bombyx mori , which is moulded into a structure that supports and promotes tissue regeneration in the joint. Their high tensile strength, flexibility and biocompatibility make silk-based materials an excellent structural implant, where the alternative is costly knee replacement surgery.

Visit website